C. Nsanzabana, D. Djalle, P. J. Guérin, D. Ménard, and I. J. González, Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape, Malar J, vol.17, p.29422048, 2018.
URL : https://hal.archives-ouvertes.fr/pasteur-02865083

, Guidelines for the treatment of malaria

G. , , p.210, 2010.

H. Noedl, Y. Se, K. Schaecher, B. L. Smith, D. Socheat et al., Evidence of Artemisinin-Resistant Malaria in Western Cambodia, N Engl J Med, vol.359, pp.2619-2620, 2008.

A. M. Dondorp, F. Nosten, P. Yi, D. Das, A. P. Phyo et al., Artemisinin Resistance in Plasmodium falciparum Malaria, N Engl J Med, vol.361, pp.455-467, 2009.
URL : https://hal.archives-ouvertes.fr/hal-02427334

E. A. Ashley, M. Dhorda, R. M. Fairhurst, C. Amaratunga, P. Lim et al., Spread of Artemisinin Resistance in Plasmodium falciparum Malaria, N Engl J Med, vol.371, pp.411-423, 2014.

F. Ariey, B. Witkowski, C. Amaratunga, J. Beghain, A. Langlois et al., A molecular marker of artemisinin-resistant Plasmodium falciparum malaria, Nature, vol.505, pp.50-55, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-00921203

S. Takala-harrison, C. G. Jacob, C. Arze, M. P. Cummings, J. C. Silva et al., Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia, J Infect Dis, vol.211, pp.670-679, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02560668

R. Leang, A. Barrette, D. M. Bouth, D. Menard, R. Abdur et al., Efficacy of Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, Antimicrob Agents Chemother, vol.57, pp.686-698, 2008.

C. Lon, J. E. Manning, P. Vanachayangkul, M. So, D. Sea et al., Efficacy of Two versus Three-Day Regimens of Dihydroartemisinin-Piperaquine for Uncomplicated Malaria in Military Personnel in Northern Cambodia: An Open-Label Randomized Trial, PLoS One, vol.9, 2014.

D. L. Saunders, P. Vanachayangkul, C. Lon, and U. S. , Army Military Malaria Research Program, National Center for Parasitology, Entomology, and Malaria Control (CNM), Royal Cambodian Armed Forces. Dihydroartemisinin-Piperaquine Failure in Cambodia, N Engl J Med, vol.371, pp.484-485, 2014.

M. D. Spring, J. T. Lin, J. E. Manning, P. Vanachayangkul, S. Somethy et al., Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study, Lancet Infect Dis, vol.15, pp.683-691, 2015.

V. Duru, N. Khim, R. Leang, S. Kim, A. Domergue et al., Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations, BMC Med, vol.13, p.305, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02560638

C. Amaratunga, P. Lim, S. Suon, S. Sreng, S. Mao et al., Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study, Lancet Infect Dis, vol.16, p.26774243, 2016.

, Geneva: World Health Organization, WHO. Status report on artemisinin and ACT resistance, p.11, 2017.

L. S. Vestergaard and P. Ringwald, Responding to the challenge of antimalarial drug resistance by routine monitoring to update national malaria treatment policies, Am J Trop Med Hyg, vol.77, pp.153-162, 2007.

, Methods for surveillance of antimalarial drug efficacy, p.85, 2009.

R. N. Price, G. Dorsey, E. A. Ashley, K. I. Barnes, J. K. Baird et al., World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs, Malar J, vol.6, p.119, 2007.

B. L. Hedt, M. K. Laufer, and T. Cohen, Drug Resistance Surveillance in Resource-Poor Settings: Current Methods and Considerations for TB, HIV, and Malaria, Am J Trop Med Hyg, vol.84, pp.192-199, 2011.

H. Noedl, Artemisinin resistance: how can we find it?, Trends Parasitol, vol.21, pp.404-409, 2005.

D. J. Bacon, R. Jambou, T. Fandeur, L. Bras, J. Wongsrichanalai et al., World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility, Malar J, vol.6, issue.120, p.17822533, 2007.

I. Versteeg and P. F. Mens, Development of a stable positive control to be used for quality assurance of rapid diagnostic tests for malaria, Diagn Microbiol Infect Dis, vol.64, pp.256-60, 2009.

N. Papa-mze, Y. D. Ndiaye, C. K. Diedhiou, S. Rahamatou, B. Dieye et al., RDTs as a source of DNA to study Plasmodium falciparum drug resistance in isolates from Senegal and the Comoros Islands, Malar J, vol.14, p.26415927, 2015.

. Who/pqdx, A risk based approach for the assessment of In vitro diagnostics (IVDs)

G. , , p.17, 2014.

S. M. Chenet, A. Okoth, S. Huber, C. S. Chandrabose, J. Lucchi et al., Independent Emergence of the Plasmodium falciparum Kelch Propeller Domain Mutant Allele C580Y in Guyana, J Infect Dis, vol.213, pp.1472-1475, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02862975

R. Abdul-ghani, A. Mt, A. -. Shibani, L. A. Allam, and A. F. , A better resolution for integrating methods for monitoring Plasmodium falciparum resistance to antimalarial drugs, Acta Trop, vol.137, pp.44-57, 2014.

S. M. Taylor, C. M. Parobek, D. K. Deconti, K. Kayentao, S. O. Coulibaly et al., Absence of Putative Artemisinin Resistance Mutations Among Plasmodium falciparum in Sub-Saharan Africa: A Molecular Epidemiologic Study, J Infect Dis, vol.211, pp.680-688, 2015.

W. H. Wernsdorfer and H. Noedl, Molecular markers for drug resistance in malaria: use in treatment, diagnosis and epidemiology, Curr Opin Infect Dis, vol.16, pp.553-561, 2003.

, malERA: An updated research agenda for insecticide and drug resistance in malaria elimination and eradication, malERA Refresh Consultative Panel on Insecticide and Drug Resistance, vol.14, p.1002450, 2017.

D. Sow, S. Nag, K. Sylla, G. O. Tine, R. C. Faye et al., Country-Wide Surveillance of Molecular Markers of Antimalarial Drug Resistance in Senegal by Use of Positive Malaria Rapid Diagnostic Tests, Am J Trop Med Hyg, vol.97, pp.1593-1596, 2017.

S. Picot, P. Olliaro, F. De-monbrison, A. Bienvenu, R. N. Price et al., A systematic review and metaanalysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria, Malar J, vol.8, p.19413906, 2009.

C. Nsanzabana, I. M. Hastings, J. Marfurt, I. Müller, K. Baea et al., Quantifying the Evolution and Impact of Antimalarial Drug Resistance: Drug Use, Spread of Resistance, and Drug Failure over a 12-Year Period in Papua New Guinea, J Infect Dis, vol.201, pp.435-443, 2010.

. Who/unicef, WHO | Intermittent preventive treatment for infants using sulfadoxine-pyrimethamine (IPTi-SP) for malaria control in Africa: implementation field guide. In: WHO [Internet]. World Health Organization, p.28, 2011.

A. R. Taylor, J. A. Flegg, S. L. Nsobya, A. Yeka, M. R. Kamya et al., Estimation of malaria haplotype and genotype frequencies: a statistical approach to overcome the challenge associated with multiclonal infections, Malar J, vol.13, p.24636676, 2014.

N. Mideo, J. A. Bailey, N. J. Hathaway, B. Ngasala, D. L. Saunders et al., A deep sequencing tool for partitioning clearance rates following antimalarial treatment in polyclonal infections, Evol Med public Heal, vol.2016, pp.21-36, 2016.

P. N. Rao, S. Uplekar, S. Kayal, P. K. Mallick, N. Bandyopadhyay et al., A Method for Amplicon Deep Sequencing of Drug Resistance Genes in Plasmodium falciparum Clinical Isolates from India. Loeffelholz MJ, editor, J Clin Microbiol, vol.54, pp.1500-1511, 2016.

P. Reteng, V. Vrisca, I. Sukarno, I. H. Djarkoni, J. A. Kalangi et al., Genetic polymorphisms in Plasmodium falciparum chloroquine resistance genes, pfcrt and pfmdr1, BMC Res Notes, vol.10, p.28376874, 2017.

E. Talundzic, Y. D. Ndiaye, A. B. Deme, C. Olsen, D. S. Patel et al., Molecular Epidemiology of Plasmodium falciparum kelch13 Mutations in Senegal Determined by Using Targeted Amplicon Deep Sequencing, Antimicrob Agents Chemother, vol.61, pp.2116-2132, 2017.

E. Talundzic, S. Ravishankar, J. Kelley, D. Patel, M. Plucinski et al., Next-Generation Sequencing and Bioinformatics Protocol for Malaria Drug Resistance Marker Surveillance, Antimicrob Agents Chemother, vol.62, pp.2474-2491, 2018.

I. M. Hastings, T. A. Smith, and C. Nsanzabana, A Comparison of Methods to Detect and Quantify the Markers of Antimalarial Drug Resistance, Am J Trop Med Hyg, vol.83, pp.10-0072, 2010.

C. M. Wilson, S. K. Volkman, S. Thaithong, R. K. Martin, D. E. Kyle et al., Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand, Mol Biochem Parasitol, vol.57, pp.151-60, 1993.

B. Witkowski, V. Duru, N. Khim, L. S. Ross, B. Saintpierre et al., A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study, Lancet Infect Dis, vol.17, issue.16, pp.30415-30422, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01400955

S. S. Vembar, M. Seetin, C. Lambert, M. Nattestad, M. C. Schatz et al., Complete telomere-totelomere de novo assembly of the Plasmodium falciparum genome through long-read (>11 kb), single molecule, real-time sequencing, DNA Res, vol.23, pp.339-351, 2016.

J. M. Bryant, S. Baumgarten, A. Lorthiois, C. Scheidig-benatar, A. Claës et al., Genome Assembly of a Plasmodium falciparum NF54 Clone Using Single-Molecule Real-Time Sequencing
URL : https://hal.archives-ouvertes.fr/hal-02321892

, Genome Announc, vol.6, 2018.

J. M. Roth, L. De-bes, P. Sawa, G. Omweri, V. Osoti et al., Plasmodium Detection and Differentiation by Direct-on-Blood PCR Nucleic Acid Lateral Flow Immunoassay: Development, Validation, and Evaluation, J Mol Diagn, vol.20, pp.78-86, 2018.

O. Miotto, R. Amato, E. A. Ashley, B. Macinnis, J. Almagro-garcia et al., Genetic architecture of artemisinin-resistant Plasmodium falciparum, Nat Genet, vol.47, pp.226-234, 2015.

, Genomic epidemiology of artemisinin resistant malaria, MalariaGEN Plasmodium falciparum Community Project, vol.5, 2016.

M. Imwong, K. Suwannasin, C. Kunasol, K. Sutawong, M. Mayxay et al., The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study, Lancet Infect Dis, vol.17, issue.17, pp.30048-30056, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02559325

C. J. Sutherland, P. Lansdell, M. Sanders, J. Muwanguzi, D. A. Van-schalkwyk et al., pfk13 -Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United Kingdom, Antimicrob Agents Chemother, vol.61, 2017.

M. Ikeda, M. Kaneko, S. Tachibana, B. Balikagala, M. Sakurai-yatsushiro et al., Artemisinin -Resistant Plasmodium falciparum with High Survival Rates, Emerg Infect Dis, vol.24, pp.718-726, 2018.

A. Khamsiriwatchara, P. Sudathip, S. Sawang, S. Vijakadge, T. Potithavoranan et al., Artemisinin resistance containment project in Thailand. (I): Implementation of electronic-based malaria information system for early case detection and individual case management in provinces along the Thai-Cambodian border, Malar J, vol.11, p.247, 2012.

N. Scott, R. Ataide, D. P. Wilson, M. Hellard, R. N. Price et al., Implications of population-level immunity for the emergence of artemisinin-resistant malaria: a mathematical model, Malar J, vol.17, p.30071877, 2018.

S. M. Taylor, A. Mayor, G. Mombo-ngoma, H. M. Kenguele, S. Ouedraogo et al., A Quality Control Program within a Clinical Trial Consortium for PCR Protocols To Detect Plasmodium Species, J Clin Microbiol, vol.52, pp.2144-2149, 2014.

S. C. Murphy, C. C. Hermsen, A. D. Douglas, N. J. Edwards, I. Petersen et al., External Quality Assurance of Malaria Nucleic Acid Testing for Clinical Trials and Eradication Surveillance. Kumar S, editor, PLoS One, vol.9, 2014.

, WHO | WHO external quality assurance scheme for malaria nucleic acid amplification testing (NAAT EQA)

, World Health Organization, 2018.